Latest News

eUpdate – Treatment Algorithms
27 Jun 2017 EMA Recommends Granting a Marketing Authorisation for Tivozanib Hydrochloride Monohydrate Genitourinary cancers - Anticancer agents & Biologic therapy
eUpdate – Treatment Recommendations
26 Jun 2017 EMA Recommends Granting a Marketing Authorisation for Ribociclib Breast cancer - Anticancer agents & Biologic therapy
23 Jun 2017 Annals of Oncology
23 Jun 2017 FDA Grants Regular Approval to Dabrafenib and Trametinib Combination for Metastatic NSCLC with BRAF V600E Mutation Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
22 Jun 2017 Efficacy Results From I-SPY 2 Trial Show Improved Outcomes with Combination Pembrolizumab Plus Standard Neoadjuvant Therapy for High-Risk Breast Cancer Breast cancer - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
21 Jun 2017 Necitumumab plus Paclitaxel-Carboplatin in first line treatment of patients with stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) Lung and other thoracic tumours
21 Jun 2017 Entry into Application of EU Clinical Trial Regulation Postponed to 2019 Bioethics, legal and economic issues
20 Jun 2017 Recommendations from the AACR Childhood Cancer Predisposition Workshop Epidemiology/Etiology/Cancer Prevention - Cancer in Special Situations
eUpdate – Treatment Recommendations
19 Jun 2017 Guide for Patients in Endometrial Cancer Now Available Also in Serbian
19 Jun 2017 Catalyzing Integration of Genomic and Clinical Datasets Across Multiple Cancer Institutions Worldwide Translational research